Content Object
(
    [className] => Content
    [contentLinks] => Array
        (
        )

    [belongsTo] => 
    [contentIssue] => 
    [id] => 311555
    [pageNumber] => 
    [offset] => 
    [totalPages] => 
    [last_query] => 
    [last_sql] => 
    [show_errors] => 1
    [databaseServer] => Array
        (
            [key] => master
            [host] => 172.24.16.232
            [user] => rodpub_beta
            [pass] => MvQQzhse92k58yA
            [db] => rodpub_beta
        )

    [tableName] => contents
    [content_type_id] => 2487
    [resource_id] => 0
    [author_id] => 0
    [primary_issue_slug] => 
    [author_name] => {"name":"Qosina Corp.","title":""}
    [magazine_id] => 6
    [layout_id] => 0
    [primary_image] => 186197
    [primary_image_old] => 
    [slider_image_id] => 186197
    [banner_image] => 0
    [title] => Qosina Announces New Chairman of Its Board of Directors
    [short_title] => 
    [summary] => Qosina’s founder and former chairman of the board has stepped down and is now chairman emeritus.
    [slug] => qosina-announces-new-chairman-of-its-board-of-dire
    [body] => Qosina Corp. and its Qosmedix division are pleased to announce the appointment of current board member, Robert Beckman, as chairman of its Board of Directors.
 
Stuart Herskovitz, Qosina’s founder and former chairman of the board, has stepped down and is now chairman emeritus.
 
Herskovitz continues to be fully involved in the company and retains his seat on the Board, but will now shift his focus to business development and attending industry trade shows.
 
“Bob brings a wealth of experience that is critical to guiding us in strategically operating our company and successfully growing our margins,” said Qosina president and CEO Scott Herskovitz. “Bob’s proven leadership, talent, expertise and support are valuable assets, and we look forward to working with him to create the next chapter of Qosina’s story of success.”
 
“I am honored to serve as chairman and work with Scott and the board to achieve further success in the years to come,” said Robert Beckman. “I look forward to building upon the track record of such an accomplished company.”
 
Beckman has served in corporate and industry leadership roles for several decades and has supported the growth and development of a wide range of global healthcare companies. He formed The Channel Group, an advisory business that provides support to global healthcare companies. Beckman also was a founder of BIO and NYBIO, where he served as chairman and in board leadership positions. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2019-04-04 09:55:00 [updated_at] => 2019-04-04 09:59:41 [last_updated_author] => 195666 [uploaded_by] => 195666 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["256198","303111","311217","218909","239624","311451","301768","305703","200026","311427","302309","301438","307989"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 [contentType] => ContentType Object ( [className] => ContentType [content] => Array ( ) [taxonomy] => Array ( ) [listURL] => [logoUrl] => https: [id] => 2487 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => content_types [tag] => breaking_news [short_tag] => breaking_news [class_name] => [display_view] => [list_view] => [slug] => breaking-news [box_view] => [ignore_flag] => 0 [image_id] => 0 [layout_id] => 0 [formattedTag] => Breaking News ) [viewURL] => /contents/view_breaking-news/2019-04-04/qosina-announces-new-chairman-of-its-board-of-dire/ [relatedArticles] => Array ( [0] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 301438 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Globe Newswire","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 177209 [primary_image_old] => [slider_image_id] => 177209 [banner_image] => 0 [title] => Daxor Corporation Appoints Chief Financial Officer [short_title] => [summary] => New hire has more than 30 years of experience in accounting and finance. [slug] => daxor-corporation-appoints-chief-financial-officer [body] => Daxor Corporation, an investment company with medical instrumentation and biotechnology operations focused on blood volume measurement, has appointed Robert J. Michel, CPA, as chief financial officer (CFO).
 
“Bob joins Daxor with significant experience across a wide array of industries, including serving on the board of a biometric solutions company . In addition, his public company expertise, combined with his comfort in working and communicating with the investor public make him an important addition to the Daxor team,” commented Michael Feldschuh, CEO of Daxor Corporation.
 
Michel joins Daxor with more than 30 years of experience in accounting and finance for companies specializing in consumer finance, engineering/manufacturing, marketing, and the healthcare industry, both privately held and publicly traded. He most recently served as CFO of at Sher-Del Transfer and Relocation Services, and prior spent seven years as CFO of Asta Funding, a publicly traded diversified financial services company. He is a certified public accountant and has a degree in business administration from the Villanova School of Business and an MBA from St. John’s University.
 
"Daxor is an exciting company with the tremendous potential for growth and value creation with its game-changing technology. I look forward to supporting the Daxor team in building the business and ensuring the overall financial health of the company, " said Michel.
 
Daxor Corporation is a medical instrumentation and biotechnology company. The company manufactures the BVA-100 Blood Volume Analyzer, the first instrument approved by the U.S. Food and Drug Administration to provide rapid direct measurement of a patient’s blood volume. Daxor believes that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is the company’s goal, working in conjunction with hospitals and clinics, to achieve that possibility. Ultimately, its mission is to help hospitals and physicians incorporate Daxor’s BVA-100 diagnostic to significantly improve the quality of patient care. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-11-01 09:09:00 [updated_at] => 2018-11-01 09:16:49 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["289346","281436","280497","298716","281299","280635","282688","300250","283697","282390","296562","282544","282670","284246"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [1] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 301768 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2721 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 177490 [primary_image_old] => [slider_image_id] => 177490 [banner_image] => 0 [title] => Qosina Adds New Bonded Extension Lines to Its Inventory [short_title] => [summary] => Qosina is pleased to introduce five new bonded, off-the-shelf extension lines [slug] => qosina-adds-new-bonded-extension-lines-to-its-inventory [body] => For Immediate Release

Qosina Adds New Bonded Extension Lines to Its Inventory

Ronkonkoma, NY, USA, November 6, 2018—Qosina is pleased to introduce five new bonded, off-the-shelf extension lines (part #s 33066-33070). Each of these extension lines are unique in that they are designed with a combination of components. Four of the sub-assemblies include both female and male luer locks, and one contains a stopcock. All five are assembled with female and male caps and various tubing lengths. Other components include a slide clamp, pinch clamp or hydrophilic filter.

These easy-to-use, cost-effective extension lines provide added flexibility to gravity and infusion sets. Because they are pre-assembled, they aid in reducing time to market in the development and production phases.

Qosina also offers a wide selection of bonded, high pressure, insert-molded and high durometer extension lines, and can provide custom configurations to meet exact specifications.

Qosina will be showcasing its new extension lines, in addition to thousands of stock components, at booth 8AL16 during the Compamed trade show at Messe Düsseldorf in Düsseldorf, Germany, November 12-15.

Founded in 1980, Qosina is a leading global supplier of OEM single-use components to the medical and pharmaceutical industries. Qosina’s philosophy is to address its customers’ need to reduce time-to-market by providing thousands of stock components. The company’s vast catalog features more than 5,000 products shown in full-scale illustrations on a one-centimeter grid. Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development. Qosina is ISO 9001, ISO 13485 and ISO 14001 registered, and operates in a 95,000 square-foot facility with an ISO Class 8 Clean Room. To learn about Qosina’s full component offering, which includes the newest products, visit www.qosina.com or call +1 (631) 242-3000.

Contact:
Qosina Corporation
Rachelle Morrow
+1 (631) 242-3000
rmorrow@qosina.com [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-11-06 11:06:00 [updated_at] => 2018-11-14 09:12:25 [last_updated_author] => 347952 [uploaded_by] => 0 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["296075","287569","296042","282712","290757","302309","301700"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [2] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 302309 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2721 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 177990 [primary_image_old] => 112195 [slider_image_id] => 177990 [banner_image] => 0 [title] => Qosina Announces the Addition of Four New Board Members [short_title] => [summary] => Qosina Corp. and its Qosmedix division are pleased to announce the appointment of four new board members [slug] => qosina-announces-the-addition-of-four-new-board-members [body] => For Immediate Release

Qosina Announces the Addition of Four New Board Members

Ronkonkoma, NY, USA, November 14, 2018—Qosina Corp. and its Qosmedix division are pleased to announce the appointment of four new board members: Pat Alesia, Robert Beckman, Ari Hoffman and Bruce Williams. The new members join the existing board of Stuart Herskovitz, Janis Herskovitz and Scott Herskovitz.

Stuart Herskovitz, Qosina’s founder and chairman of the board, said, “We are delighted to welcome these talented leaders to our board of directors. Their combined industry expertise, operational leadership and proven track record of profitability will help propel Qosina and Qosmedix into the next stage of growth.”

“We are confident Qosina and Qosmedix will benefit greatly from the guidance of the new members due to their business acumen and expertise,” said Scott Herskovitz, president and CEO of Qosina. “Their experience across global markets will undoubtedly add a valuable perspective to our board.”

Mr. Alesia is the former senior vice president, CFO and chief administrative officer of Griffon Corporation (NYSE: GFF), where he was employed for nearly 40 years. After his retirement in 2013, he commenced serving Griffon Corporation in a consulting role. In 2015, Mr. Alesia formed Alesia Consultants, lending his vast experience in finance, accounting, compliance, risk management and cyber security as a strategic consultant to other corporate clients.

Mr. Beckman has served in corporate and industry leadership for several decades and has supported the growth and development of a wide range of global healthcare companies. He formed The Channel Group, an advisory business that provides support to global healthcare companies. Mr. Beckman also was a founder of BIO and NYBIO, where he served as chairman and in board leadership positions.

Mr. Hoffman is currently the CEO of Scotch & Soda USA and has been a fashion industry executive for over 30 years, working at leading brands including Yves Saint Laurent, —MORE— —2— Christian Lacroix, St. John, Lacoste, GANT and Benetton. He has been ranked on the fashion industry’s Power 100 list and served on the retail advisory board of NYC and Co.

Mr. Williams’ professional background crosses many end-product markets and a wide variety of product applications, the majority being with healthcare OEMs. Mr. Williams’ previous roles include engineering manager, vice president of sales and marketing, COO and CEO during his tenure with Value Plastics, Inc.

Founded in 1980, Qosina is a leading global supplier of OEM single-use components to the medical and pharmaceutical industries. Qosina’s philosophy is to address its customers’ need to reduce time to market by providing thousands of stock components. The company’s vast catalog features more than 5,000 products shown in full-scale illustrations on a one-centimeter grid. Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development. Qosina is ISO 9001, ISO 13485 and ISO 14001 certified, and operates in a 95,000 square-foot facility with an ISO Class 8 Clean Room. To learn about Qosina’s full component offering, visit the company’s newly redesigned e-commerce website at www.qosina.com, or call +1 (631) 242-3000.

Qosmedix is an ISO 9001 and ISO 14001 certified global supplier to the cosmetic, skin care, spa and salon industries. Founded on the concept of maintaining hygienic practices during beauty consultations, the company has expanded to provide an array of high quality products that offer convenience and value to its customers. The vast inventory includes brushes, swabs, applicators, disposable spa wear, jars, bottles and more. For assistance with sample requests, orders or customization inquiries, please contact a customer specialist by phone: +1 (631) 242-3270, fax: +1 (631) 242-3291, or email: info@qosmedix.com. Ask to receive the latest catalog, or visit www.qosmedix.com to view the complete product line. Qosmedix is a division of Qosina, a leading international supplier of components to the medical and pharmaceutical industries.

Contact:
Qosina Corp.
Rachelle Morrow
+1 (631) 242-3000
rmorrow@qosina.com

Qosmedix
Danielle Venticinque
+1 (631) 242-3270
dventicinque@qosmedix.com [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-11-14 09:03:00 [updated_at] => 2018-11-14 09:20:33 [last_updated_author] => 347952 [uploaded_by] => 0 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["300924","300499","284682","296042","296075","287569","282712","290757","301768","302068","281185","301700","302314"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [3] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 303111 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2721 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 178686 [primary_image_old] => [slider_image_id] => 178686 [banner_image] => 0 [title] => Qosina Announces E-commerce Website Update [short_title] => [summary] => Qosina is pleased to announce the launch of its newly redesigned e-commerce website. [slug] => qosina-announces-e-commerce-website-update [body] => For Immediate Release
 
Qosina Announces E-commerce Website Update

Ronkonkoma, NY, USA, November 28, 2018—Qosina is pleased to announce the launch of its newly redesigned e-commerce website.
 
The new website provides improved navigation and easier access to Qosina’s products and services. Other new features include an updated product category structure, category-specific filtering to easily find components, and the addition of downloadable documentation such as safety data sheets, technical data sheets and compatibility information to ensure customers are qualifying the appropriate material for their project.
 
“Our previous website’s features and functionality haven’t changed,” said Scott Herskovitz, Qosina’s president and CEO. “Qosina still offers the largest variety of in-stock medical and OEM components available to order 24/7. But we’ve enhanced our e-commerce store by creating a more interactive and meaningful customer experience. We worked hard to make the new site practical and useful, but more importantly, we filled it with valuable content and tools that our customers have been requesting.”
 
To see all the new features Qosina’s newly redesigned website has to offer, please visit www.qosina.com.
 
Founded in 1980, Qosina is a leading global supplier of OEM single-use components to the medical and pharmaceutical industries. Qosina’s philosophy is to address its customers’ need to reduce time to market by providing thousands of stock components. The company’s vast catalog features more than 5,000 products shown in full-scale illustrations on a one-centimeter grid. Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development. Qosina is ISO 9001, ISO 13485 and ISO 14001 certified, and operates in a 95,000 square-foot facility with an ISO Class 8 Clean Room. To learn about Qosina’s full component offering, which includes the newest products,
visit www.qosina.com or call +1 (631) 242-3000. 

Contact:        Qosina Corp.
                      Rachelle Morrow
                      +1 (631) 242-3000
                      rmorrow@qosina.com  [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-11-28 14:50:00 [updated_at] => 2018-11-28 15:24:05 [last_updated_author] => 159061 [uploaded_by] => 0 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["301768","296075","287569","296042","302309","282712","290757","290316","302847","302931","297162","288057","293287","290172","300013","302547"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [4] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 305703 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2492 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Becca Fantano, Marketing Communications Specialist, Performance Materials, Evonik Cyro","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 180734 [primary_image_old] => 114847 [slider_image_id] => 180733 [banner_image] => 0 [title] => Off-Shelf to In-House: Upgrade in Material Enhances Customer Satisfaction [short_title] => [summary] => Qosina utilizes CYROLITE G-20 HIFLO to create new disposable luer lock connector. [slug] => off-shelf-to-in-house-upgrade-in-material-enhances-customer-satisfaction [body] => In the world of disposable medical devices, component distributors rely heavily on off-the-shelf stock products to fulfill both large and small component orders. Whether meeting the needs of established OEMs, mid-sized device manufacturers, startups, or engineers developing and testing new designs, these distributors need to react quickly to changing industry demands while guaranteeing consistent quality across thousands of medical-grade parts.
 
In the case of Qosina, a global supplier of single-use medical device components, off-the-shelf components make up the majority of their product lines, which range from tubing, valves, and stopcocks to an array of highly specialized connectors. Being that Qosina was founded as a way for customers to eliminate the cost of tooling their own components and reap the benefits of immediate component delivery, the company must maintain a watchful eye on product availability.
 
The Need for Custom Molds and Specialized Products
Qosina invariably comes upon situations where product procurement strategies need to be reassessed and adjusted. In 2016, such a case arose and Qosina found that it would no longer be able to keep up with customer demand for a specialized luer lock connector (Figure 1) due to increases in production times that were creating supply issues.
 
Qosina determined that making an investment in their own tooling and initiating their own molding program would give the company complete control over the connector in question. This would also eradicate any and all problems related to lead times and molding issues, as well as eliminate the potential for component cost increases that could be felt by Qosina’s customers.
 
The last piece of the equation was the material. To maintain production processes and end-user performance, the goal at this stage was to choose a component material that would mirror the previously used material and offer similar molding and usage properties.
 
“Delays in manufacturing were creating issues for us in terms of meeting customer demand in a timely fashion,” said Geri Trautman, product development manager at Qosina. “So, after we started working on our own tooling and our own molding source, we began talking with Evonik regarding the material that would best suit this new product. Evonik pointed us in a new direction, toward their CYROLITE G-20 HIFLO, a material that is easy to process and saves us considerable production costs over the long run.”
 
CYROLITE G-20 HIFLO Medical Acrylic
Evonik’s CYROLITE G-20 HIFLO acrylic-based copolymer compound is used primarily for the production of disposable medical devices (Figure 2). It has been in use in the medical market for over 30 years.
 
A BPA-free, impact-modified copolymer for the injection molding and extrusion of medical devices, CYROLITE G-20 HIFLO offers a number of benefits that made it an ideal fit for the Qosina luer lock connector. With a balance of physical properties and chemical resistance, CYROLITE offers excellent processability and flow characteristics for extremely thin-walled applications and complex multi-cavity molds. In addition, CYROLITE can be bonded to PVC tubing and sterilized by EtO gas and gamma irradiation.
 
“At this stage, we determined that CYROLITE was the optimal material for the part in question,” said Trautman. “We ended up with a better-performing material that we may not have even considered without Evonik’s input.”
 
Prototyping, Testing, and Production
Following prototyping and testing, Qosina was extremely satisfied to learn that this new luer lock connector, produced in-house through a partnership with an independent molding company, exceeded all performance specifications.
 
In addition, the use of CYROLITE G-20 HIFLO lowered the cost of production due to lower required mold temperatures, ease in processability, and faster cycle times. In the end, Qosina was able to pass these savings onto its customers, offering them a luer lock connector that delivered or exceeded all previous performance expectations at a lower cost.
 
“This efficiency in the production process, coupled with proven performance capabilities, made this a win-win across the board for us,” said Michael Gillis, supplier relations manager at Qosina. “We were able to make more parts in less time, enjoy less downtime on the molding machine, and also take advantage of energy cost savings due to increased productivity.”
 
In the case of CYROLITE G-20 HIFLO, many customers were already familiar with the material and product name, making the switch that much easier for Qosina and their customers.
 
With 100 percent of customers who had used the previous luer lock connector choosing to make the switch to the new product, Qosina has experienced an extremely successful transition to CYROLITE G-20 HIFLO. Up until this point, Qosina has also reported 100 percent customer satisfaction with the new luer lock connector, with no issues being reported in terms of usability, performance, or delivery times.
 
“When customers come to us for material recommendation, collaboration is important to ensure that all stakeholders share the application requirements and material knowledge. This is key to selecting the right material for the application and ensuring the long-term success of the medical device,” said Maurice Biagini, commercial director at Evonik. “In this case, CYROLITE G-20 HIFLO was the perfect choice for the application because it has the right balance of physical properties and excellent processability.”
 
A Successful Collaboration—A Promising Future
Though this was Qosina’s first foray into a product manufacturing arrangement of this nature, their partnership with Evonik has proven to be beneficial for both companies, as well as Qosina’s customers. Qosina is now positioned to continue to create their own components using their in-house tooling. In fact, Qosina has already begun a second project with Evonik under the same arrangement and is looking forward to the same results.
 
“Our partnership with Evonik is allowing us to better control costs, production, and the quality of our end product,” concluded Trautman. “Based on product demand, we will continue to look for areas where this approach makes sense for us. We look forward to continuing our partnership with Evonik for many years to come.”
 
“This project was an excellent example of collaboration between Evonik and Qosina. In fact, it was seamless every step of the way, which is sometimes a challenge in our industry,” added Biagini. “Both companies collaborated creatively and identified the best solution to meet the market needs. We are extremely excited about continuing the partnership that we have started with Qosina.” [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2019-01-14 09:31:00 [updated_at] => 2019-01-14 09:33:57 [last_updated_author] => 195666 [uploaded_by] => 195666 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["303111","301768","296075","296042","302309","305072","290757","302063","291499","293192","114841","305246","305696","302816","301875","302037"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) ) [relatedContent] => Array ( [0] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 301438 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Globe Newswire","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 177209 [primary_image_old] => [slider_image_id] => 177209 [banner_image] => 0 [title] => Daxor Corporation Appoints Chief Financial Officer [short_title] => [summary] => New hire has more than 30 years of experience in accounting and finance. [slug] => daxor-corporation-appoints-chief-financial-officer [body] => Daxor Corporation, an investment company with medical instrumentation and biotechnology operations focused on blood volume measurement, has appointed Robert J. Michel, CPA, as chief financial officer (CFO).
 
“Bob joins Daxor with significant experience across a wide array of industries, including serving on the board of a biometric solutions company . In addition, his public company expertise, combined with his comfort in working and communicating with the investor public make him an important addition to the Daxor team,” commented Michael Feldschuh, CEO of Daxor Corporation.
 
Michel joins Daxor with more than 30 years of experience in accounting and finance for companies specializing in consumer finance, engineering/manufacturing, marketing, and the healthcare industry, both privately held and publicly traded. He most recently served as CFO of at Sher-Del Transfer and Relocation Services, and prior spent seven years as CFO of Asta Funding, a publicly traded diversified financial services company. He is a certified public accountant and has a degree in business administration from the Villanova School of Business and an MBA from St. John’s University.
 
"Daxor is an exciting company with the tremendous potential for growth and value creation with its game-changing technology. I look forward to supporting the Daxor team in building the business and ensuring the overall financial health of the company, " said Michel.
 
Daxor Corporation is a medical instrumentation and biotechnology company. The company manufactures the BVA-100 Blood Volume Analyzer, the first instrument approved by the U.S. Food and Drug Administration to provide rapid direct measurement of a patient’s blood volume. Daxor believes that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is the company’s goal, working in conjunction with hospitals and clinics, to achieve that possibility. Ultimately, its mission is to help hospitals and physicians incorporate Daxor’s BVA-100 diagnostic to significantly improve the quality of patient care. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-11-01 09:09:00 [updated_at] => 2018-11-01 09:16:49 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["289346","281436","280497","298716","281299","280635","282688","300250","283697","282390","296562","282544","282670","284246"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [1] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 301768 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2721 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 177490 [primary_image_old] => [slider_image_id] => 177490 [banner_image] => 0 [title] => Qosina Adds New Bonded Extension Lines to Its Inventory [short_title] => [summary] => Qosina is pleased to introduce five new bonded, off-the-shelf extension lines [slug] => qosina-adds-new-bonded-extension-lines-to-its-inventory [body] => For Immediate Release

Qosina Adds New Bonded Extension Lines to Its Inventory

Ronkonkoma, NY, USA, November 6, 2018—Qosina is pleased to introduce five new bonded, off-the-shelf extension lines (part #s 33066-33070). Each of these extension lines are unique in that they are designed with a combination of components. Four of the sub-assemblies include both female and male luer locks, and one contains a stopcock. All five are assembled with female and male caps and various tubing lengths. Other components include a slide clamp, pinch clamp or hydrophilic filter.

These easy-to-use, cost-effective extension lines provide added flexibility to gravity and infusion sets. Because they are pre-assembled, they aid in reducing time to market in the development and production phases.

Qosina also offers a wide selection of bonded, high pressure, insert-molded and high durometer extension lines, and can provide custom configurations to meet exact specifications.

Qosina will be showcasing its new extension lines, in addition to thousands of stock components, at booth 8AL16 during the Compamed trade show at Messe Düsseldorf in Düsseldorf, Germany, November 12-15.

Founded in 1980, Qosina is a leading global supplier of OEM single-use components to the medical and pharmaceutical industries. Qosina’s philosophy is to address its customers’ need to reduce time-to-market by providing thousands of stock components. The company’s vast catalog features more than 5,000 products shown in full-scale illustrations on a one-centimeter grid. Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development. Qosina is ISO 9001, ISO 13485 and ISO 14001 registered, and operates in a 95,000 square-foot facility with an ISO Class 8 Clean Room. To learn about Qosina’s full component offering, which includes the newest products, visit www.qosina.com or call +1 (631) 242-3000.

Contact:
Qosina Corporation
Rachelle Morrow
+1 (631) 242-3000
rmorrow@qosina.com [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-11-06 11:06:00 [updated_at] => 2018-11-14 09:12:25 [last_updated_author] => 347952 [uploaded_by] => 0 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["296075","287569","296042","282712","290757","302309","301700"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [2] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 302309 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2721 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 177990 [primary_image_old] => 112195 [slider_image_id] => 177990 [banner_image] => 0 [title] => Qosina Announces the Addition of Four New Board Members [short_title] => [summary] => Qosina Corp. and its Qosmedix division are pleased to announce the appointment of four new board members [slug] => qosina-announces-the-addition-of-four-new-board-members [body] => For Immediate Release

Qosina Announces the Addition of Four New Board Members

Ronkonkoma, NY, USA, November 14, 2018—Qosina Corp. and its Qosmedix division are pleased to announce the appointment of four new board members: Pat Alesia, Robert Beckman, Ari Hoffman and Bruce Williams. The new members join the existing board of Stuart Herskovitz, Janis Herskovitz and Scott Herskovitz.

Stuart Herskovitz, Qosina’s founder and chairman of the board, said, “We are delighted to welcome these talented leaders to our board of directors. Their combined industry expertise, operational leadership and proven track record of profitability will help propel Qosina and Qosmedix into the next stage of growth.”

“We are confident Qosina and Qosmedix will benefit greatly from the guidance of the new members due to their business acumen and expertise,” said Scott Herskovitz, president and CEO of Qosina. “Their experience across global markets will undoubtedly add a valuable perspective to our board.”

Mr. Alesia is the former senior vice president, CFO and chief administrative officer of Griffon Corporation (NYSE: GFF), where he was employed for nearly 40 years. After his retirement in 2013, he commenced serving Griffon Corporation in a consulting role. In 2015, Mr. Alesia formed Alesia Consultants, lending his vast experience in finance, accounting, compliance, risk management and cyber security as a strategic consultant to other corporate clients.

Mr. Beckman has served in corporate and industry leadership for several decades and has supported the growth and development of a wide range of global healthcare companies. He formed The Channel Group, an advisory business that provides support to global healthcare companies. Mr. Beckman also was a founder of BIO and NYBIO, where he served as chairman and in board leadership positions.

Mr. Hoffman is currently the CEO of Scotch & Soda USA and has been a fashion industry executive for over 30 years, working at leading brands including Yves Saint Laurent, —MORE— —2— Christian Lacroix, St. John, Lacoste, GANT and Benetton. He has been ranked on the fashion industry’s Power 100 list and served on the retail advisory board of NYC and Co.

Mr. Williams’ professional background crosses many end-product markets and a wide variety of product applications, the majority being with healthcare OEMs. Mr. Williams’ previous roles include engineering manager, vice president of sales and marketing, COO and CEO during his tenure with Value Plastics, Inc.

Founded in 1980, Qosina is a leading global supplier of OEM single-use components to the medical and pharmaceutical industries. Qosina’s philosophy is to address its customers’ need to reduce time to market by providing thousands of stock components. The company’s vast catalog features more than 5,000 products shown in full-scale illustrations on a one-centimeter grid. Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development. Qosina is ISO 9001, ISO 13485 and ISO 14001 certified, and operates in a 95,000 square-foot facility with an ISO Class 8 Clean Room. To learn about Qosina’s full component offering, visit the company’s newly redesigned e-commerce website at www.qosina.com, or call +1 (631) 242-3000.

Qosmedix is an ISO 9001 and ISO 14001 certified global supplier to the cosmetic, skin care, spa and salon industries. Founded on the concept of maintaining hygienic practices during beauty consultations, the company has expanded to provide an array of high quality products that offer convenience and value to its customers. The vast inventory includes brushes, swabs, applicators, disposable spa wear, jars, bottles and more. For assistance with sample requests, orders or customization inquiries, please contact a customer specialist by phone: +1 (631) 242-3270, fax: +1 (631) 242-3291, or email: info@qosmedix.com. Ask to receive the latest catalog, or visit www.qosmedix.com to view the complete product line. Qosmedix is a division of Qosina, a leading international supplier of components to the medical and pharmaceutical industries.

Contact:
Qosina Corp.
Rachelle Morrow
+1 (631) 242-3000
rmorrow@qosina.com

Qosmedix
Danielle Venticinque
+1 (631) 242-3270
dventicinque@qosmedix.com [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-11-14 09:03:00 [updated_at] => 2018-11-14 09:20:33 [last_updated_author] => 347952 [uploaded_by] => 0 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["300924","300499","284682","296042","296075","287569","282712","290757","301768","302068","281185","301700","302314"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [3] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 303111 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2721 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 178686 [primary_image_old] => [slider_image_id] => 178686 [banner_image] => 0 [title] => Qosina Announces E-commerce Website Update [short_title] => [summary] => Qosina is pleased to announce the launch of its newly redesigned e-commerce website. [slug] => qosina-announces-e-commerce-website-update [body] => For Immediate Release
 
Qosina Announces E-commerce Website Update

Ronkonkoma, NY, USA, November 28, 2018—Qosina is pleased to announce the launch of its newly redesigned e-commerce website.
 
The new website provides improved navigation and easier access to Qosina’s products and services. Other new features include an updated product category structure, category-specific filtering to easily find components, and the addition of downloadable documentation such as safety data sheets, technical data sheets and compatibility information to ensure customers are qualifying the appropriate material for their project.
 
“Our previous website’s features and functionality haven’t changed,” said Scott Herskovitz, Qosina’s president and CEO. “Qosina still offers the largest variety of in-stock medical and OEM components available to order 24/7. But we’ve enhanced our e-commerce store by creating a more interactive and meaningful customer experience. We worked hard to make the new site practical and useful, but more importantly, we filled it with valuable content and tools that our customers have been requesting.”
 
To see all the new features Qosina’s newly redesigned website has to offer, please visit www.qosina.com.
 
Founded in 1980, Qosina is a leading global supplier of OEM single-use components to the medical and pharmaceutical industries. Qosina’s philosophy is to address its customers’ need to reduce time to market by providing thousands of stock components. The company’s vast catalog features more than 5,000 products shown in full-scale illustrations on a one-centimeter grid. Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development. Qosina is ISO 9001, ISO 13485 and ISO 14001 certified, and operates in a 95,000 square-foot facility with an ISO Class 8 Clean Room. To learn about Qosina’s full component offering, which includes the newest products,
visit www.qosina.com or call +1 (631) 242-3000. 

Contact:        Qosina Corp.
                      Rachelle Morrow
                      +1 (631) 242-3000
                      rmorrow@qosina.com  [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-11-28 14:50:00 [updated_at] => 2018-11-28 15:24:05 [last_updated_author] => 159061 [uploaded_by] => 0 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["301768","296075","287569","296042","302309","282712","290757","290316","302847","302931","297162","288057","293287","290172","300013","302547"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [4] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 305703 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2492 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Becca Fantano, Marketing Communications Specialist, Performance Materials, Evonik Cyro","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 180734 [primary_image_old] => 114847 [slider_image_id] => 180733 [banner_image] => 0 [title] => Off-Shelf to In-House: Upgrade in Material Enhances Customer Satisfaction [short_title] => [summary] => Qosina utilizes CYROLITE G-20 HIFLO to create new disposable luer lock connector. [slug] => off-shelf-to-in-house-upgrade-in-material-enhances-customer-satisfaction [body] => In the world of disposable medical devices, component distributors rely heavily on off-the-shelf stock products to fulfill both large and small component orders. Whether meeting the needs of established OEMs, mid-sized device manufacturers, startups, or engineers developing and testing new designs, these distributors need to react quickly to changing industry demands while guaranteeing consistent quality across thousands of medical-grade parts.
 
In the case of Qosina, a global supplier of single-use medical device components, off-the-shelf components make up the majority of their product lines, which range from tubing, valves, and stopcocks to an array of highly specialized connectors. Being that Qosina was founded as a way for customers to eliminate the cost of tooling their own components and reap the benefits of immediate component delivery, the company must maintain a watchful eye on product availability.
 
The Need for Custom Molds and Specialized Products
Qosina invariably comes upon situations where product procurement strategies need to be reassessed and adjusted. In 2016, such a case arose and Qosina found that it would no longer be able to keep up with customer demand for a specialized luer lock connector (Figure 1) due to increases in production times that were creating supply issues.
 
Qosina determined that making an investment in their own tooling and initiating their own molding program would give the company complete control over the connector in question. This would also eradicate any and all problems related to lead times and molding issues, as well as eliminate the potential for component cost increases that could be felt by Qosina’s customers.
 
The last piece of the equation was the material. To maintain production processes and end-user performance, the goal at this stage was to choose a component material that would mirror the previously used material and offer similar molding and usage properties.
 
“Delays in manufacturing were creating issues for us in terms of meeting customer demand in a timely fashion,” said Geri Trautman, product development manager at Qosina. “So, after we started working on our own tooling and our own molding source, we began talking with Evonik regarding the material that would best suit this new product. Evonik pointed us in a new direction, toward their CYROLITE G-20 HIFLO, a material that is easy to process and saves us considerable production costs over the long run.”
 
CYROLITE G-20 HIFLO Medical Acrylic
Evonik’s CYROLITE G-20 HIFLO acrylic-based copolymer compound is used primarily for the production of disposable medical devices (Figure 2). It has been in use in the medical market for over 30 years.
 
A BPA-free, impact-modified copolymer for the injection molding and extrusion of medical devices, CYROLITE G-20 HIFLO offers a number of benefits that made it an ideal fit for the Qosina luer lock connector. With a balance of physical properties and chemical resistance, CYROLITE offers excellent processability and flow characteristics for extremely thin-walled applications and complex multi-cavity molds. In addition, CYROLITE can be bonded to PVC tubing and sterilized by EtO gas and gamma irradiation.
 
“At this stage, we determined that CYROLITE was the optimal material for the part in question,” said Trautman. “We ended up with a better-performing material that we may not have even considered without Evonik’s input.”
 
Prototyping, Testing, and Production
Following prototyping and testing, Qosina was extremely satisfied to learn that this new luer lock connector, produced in-house through a partnership with an independent molding company, exceeded all performance specifications.
 
In addition, the use of CYROLITE G-20 HIFLO lowered the cost of production due to lower required mold temperatures, ease in processability, and faster cycle times. In the end, Qosina was able to pass these savings onto its customers, offering them a luer lock connector that delivered or exceeded all previous performance expectations at a lower cost.
 
“This efficiency in the production process, coupled with proven performance capabilities, made this a win-win across the board for us,” said Michael Gillis, supplier relations manager at Qosina. “We were able to make more parts in less time, enjoy less downtime on the molding machine, and also take advantage of energy cost savings due to increased productivity.”
 
In the case of CYROLITE G-20 HIFLO, many customers were already familiar with the material and product name, making the switch that much easier for Qosina and their customers.
 
With 100 percent of customers who had used the previous luer lock connector choosing to make the switch to the new product, Qosina has experienced an extremely successful transition to CYROLITE G-20 HIFLO. Up until this point, Qosina has also reported 100 percent customer satisfaction with the new luer lock connector, with no issues being reported in terms of usability, performance, or delivery times.
 
“When customers come to us for material recommendation, collaboration is important to ensure that all stakeholders share the application requirements and material knowledge. This is key to selecting the right material for the application and ensuring the long-term success of the medical device,” said Maurice Biagini, commercial director at Evonik. “In this case, CYROLITE G-20 HIFLO was the perfect choice for the application because it has the right balance of physical properties and excellent processability.”
 
A Successful Collaboration—A Promising Future
Though this was Qosina’s first foray into a product manufacturing arrangement of this nature, their partnership with Evonik has proven to be beneficial for both companies, as well as Qosina’s customers. Qosina is now positioned to continue to create their own components using their in-house tooling. In fact, Qosina has already begun a second project with Evonik under the same arrangement and is looking forward to the same results.
 
“Our partnership with Evonik is allowing us to better control costs, production, and the quality of our end product,” concluded Trautman. “Based on product demand, we will continue to look for areas where this approach makes sense for us. We look forward to continuing our partnership with Evonik for many years to come.”
 
“This project was an excellent example of collaboration between Evonik and Qosina. In fact, it was seamless every step of the way, which is sometimes a challenge in our industry,” added Biagini. “Both companies collaborated creatively and identified the best solution to meet the market needs. We are extremely excited about continuing the partnership that we have started with Qosina.” [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2019-01-14 09:31:00 [updated_at] => 2019-01-14 09:33:57 [last_updated_author] => 195666 [uploaded_by] => 195666 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["303111","301768","296075","296042","302309","305072","290757","302063","291499","293192","114841","305246","305696","302816","301875","302037"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) ) [relatedSearches] => Array ( [0] => Taxonomy Object ( [className] => Taxonomy [id] => 59150 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [taxonomy_tag] => ceo ) [1] => Taxonomy Object ( [className] => Taxonomy [id] => 59149 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [taxonomy_tag] => president ) [2] => Taxonomy Object ( [className] => Taxonomy [id] => 67798 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [taxonomy_tag] => scott herskovitz ) [3] => Taxonomy Object ( [className] => Taxonomy [id] => 63698 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [taxonomy_tag] => track ) ) [contentTaxonomy_knowledge-center] => Array ( ) [formattedTitle] => Qosina Announces New Chairman Of Its Board Of Directors [taxonomy_keywords] => Array ( [0] => Taxonomy Object ( [className] => Taxonomy [id] => 54797 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => qosina [slug] => qosina [child_of] => 24495 ) [1] => Taxonomy Object ( [className] => Taxonomy [id] => 56972 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => healthcare [slug] => healthcare [child_of] => 24495 ) [2] => Taxonomy Object ( [className] => Taxonomy [id] => 59080 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => development [slug] => development [child_of] => 24495 ) [3] => Taxonomy Object ( [className] => Taxonomy [id] => 59149 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => president [slug] => president [child_of] => 24495 ) [4] => Taxonomy Object ( [className] => Taxonomy [id] => 59150 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => ceo [slug] => ceo [child_of] => 24495 ) [5] => Taxonomy Object ( [className] => Taxonomy [id] => 60296 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => forward [slug] => forward [child_of] => 24495 ) [6] => Taxonomy Object ( [className] => Taxonomy [id] => 63698 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => track [slug] => track [child_of] => 24495 ) [7] => Taxonomy Object ( [className] => Taxonomy [id] => 64227 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => company [slug] => company [child_of] => 24495 ) [8] => Taxonomy Object ( [className] => Taxonomy [id] => 67798 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => scott herskovitz [slug] => scott-herskovitz [child_of] => 24495 ) ) )